Emdrix Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2012.
2012 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals Private Limited, a active private limited company, was established on 03 September 2012 in Bangalore, Karnataka, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U85191KA2012PTC065703. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.09 M.

It upholds a active non-compliant status. Employing 1 professional, Its leadership includes Niranjan Surendra Shetty (Director), Namitha Ananth (Whole-Time Director), Subbaraju Ananth Narasimha (Whole-Time Director). Past directors included Niranjan Surendra Shetty, Namitha Ananth, Subbaraju Ananth Narasimha. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at No.100, Gokaram Tower, 4Th Floor, Portion-A,1St Ma In, 5Th Cross, New Timber Yard Layout, M, Ysore Road, Bangalore, Karnataka, 560026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85191KA2012PTC065703

  • Registration Number

    065703

  • Incorporation Date

    03 September 2012

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹1.09 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 1.09 M
  • Company Age 13 Year, 8 Months
  • Last Filing with ROC 31 Mar 2017
  • Open Charges ₹ 2.00 Cr
  • Revenue Growth **** 72.67%
  • Profit Growth **** -3430.09%
  • Ebitda **** -628.13%
  • Net Worth -345.77%
  • Total Assets **** 56.89%
Company report

Emdrix Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Emdrix Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Emdrix Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Niranjan Surendra Shetty Director 16 Jul 2016 Current
Namitha Ananth Whole-Time Director 03 Sep 2012 Current
Subbaraju Ananth Narasimha Whole-Time Director 03 Sep 2012 Current
Sharmarashmi Whole-Time Director 03 Sep 2012 Current
Hindupur Narasingarao Udayasimha Whole-Time Director 03 Sep 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 08 Dec 2016 Past
Pramod Abcsdd Director 30 Sep 2014 Past
Pramod Abcsdd Director 30 Sep 2014 Past
Pramod Abcsdd Whole-Time Director 19 Mar 2016 Past
Pramod Abcsdd Director 30 Sep 2014 Past
Pramod Abcsdd Director 30 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emdrix Pharmaceuticals.

Emdrix Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 72.67% increase. The company also saw a substantial fall in profitability, with a 3430.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 345.77%.

Emdrix Pharmaceuticals revenue growth over time
Emdrix Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 72.67%
*******
*******
*******
*******
Revenue from Operations
*******
 72.69%
*******
*******
*******
*******
Total Assets
*******
 56.89%
*******
*******
*******
*******
Profit or Loss
*******
 -3430.09%
*******
*******
*******
*******
Net Worth
*******
 -345.77%
*******
*******
*******
*******
EBITDA
*******
 -628.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emdrix Pharmaceuticals?

In 2017, Emdrix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of Mysore : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
26 May 2015 State Bank Of Mysore ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Emdrix Pharmaceuticals?

Emdrix Pharmaceuticals has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emdrix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emdrix Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emdrix Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Emdrix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Emdrix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Bangalore. was documented.

  • Director Appointment

    Niranjan Surendra Shetty was appointed as a Director was appointed as a Director on 16 Jul 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of Mysore amounted to Rs. 20.00 M with Charge ID 10574477 was registered on 26 May 2015. was documented.

  • Director Appointment

    The activity Namitha Ananth was appointed as a Whole-time director was appointed as a Whole-time director on 03 Sep 2012 & has been associated with this company since 13 years 8 months . was completed.

  • Director Appointment

    Subbaraju Ananth Narasimha was appointed as a Whole-time director was appointed as a Whole-time director on 03 Sep 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Emdrix Pharmaceuticals Private Limited?

The CIN of Emdrix Pharmaceuticals Private Limited is U85191KA2012PTC065703.

Where is Emdrix Pharmaceuticals Private Limited headquartered?

Emdrix Pharmaceuticals Private Limited is headquartered at No.100, Gokaram Tower, 4Th Floor, Portion-A,1St Ma In, 5Th Cross, New Timber Yard Layout, M, Ysore Road, Bangalore, Karnataka, 560026.

When was Emdrix Pharmaceuticals Private Limited incorporated?

Emdrix Pharmaceuticals Private Limited was incorporated on 03 September 2012.

Who are the current directors of Emdrix Pharmaceuticals Private Limited?

The current directors of Emdrix Pharmaceuticals Private Limited are

What is the primary industry of Emdrix Pharmaceuticals Private Limited?

The primary industry of Emdrix Pharmaceuticals Private Limited is Trade.

Is Emdrix Pharmaceuticals Private Limited a listed company?

Emdrix Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Emdrix Pharmaceuticals Private Limited?

The authorized capital of Emdrix Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹1.09 M.

What is the compliance status of Emdrix Pharmaceuticals Private Limited?

The compliance status of Emdrix Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available